WallStreetZenWallStreetZen

NASDAQ: ICAD
Icad Inc Stock

Open Broker Account
$1.72-0.08 (-4.44%)
Updated Dec 1, 2022
ICAD Price
$1.72
Fair Value Price
$2.70
Market Cap
$43.77M
52 Week Low
$1.61
52 Week High
$7.65
P/E
-3.02x
P/B
1.16x
P/S
1.81x
PEG
N/A
Dividend Yield
N/A
Revenue
$29.26M
Earnings
-$14.71M
Gross Margin
71.4%
Operating Margin
-50.2%
Profit Margin
-50.3%
Debt to Equity
0.47
Operating Cash Flow
-$11M
Beta
0.96
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ICAD Overview

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a tool that provides breast cancer risk estimation based on a screening mammogram; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ICAD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ICAD ($1.72) is undervalued by 36.23% relative to our estimate of its Fair Value price of $2.70 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ICAD ($1.72) is significantly undervalued by 36.23% relative to our estimate of its Fair Value price of $2.70 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ICAD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ICAD due diligence checks available for Premium users.

Be the first to know about important ICAD news, forecast changes, insider trades & much more!

ICAD News

Valuation

ICAD fair value

Fair Value of ICAD stock based on Discounted Cash Flow (DCF)
Price
$1.72
Fair Value
$2.70
Undervalued by
36.23%
ICAD ($1.72) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ICAD ($1.72) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ICAD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ICAD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.02x
Industry
20.39x
Market
22.16x

ICAD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.16x
Industry
2.89x
ICAD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ICAD's financial health

Profit margin

Revenue
$6.4M
Net Income
-$3.9M
Profit Margin
-61.3%
ICAD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ICAD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$55.4M
Liabilities
$17.7M
Debt to equity
0.47
ICAD's short-term assets ($42.48M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ICAD's short-term assets ($42.48M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ICAD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ICAD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.7M
Investing
-$100.0k
Financing
$161.0k
ICAD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ICAD vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
ICAD$43.77M-4.44%-3.02x1.16x
AUGX$44.17M-5.60%-1.76x6.85x
MTBC$51.14M+0.90%-7.64x0.50x
UPH$51.23M+0.87%-0.11x0.18x
EUDA$52.48M-3.10%-1.34x-47.17x

Icad Stock FAQ

What is Icad's quote symbol?

NASDAQ: ICAD) Icad trades on the NASDAQ under the ticker symbol ICAD. Icad stock quotes can also be displayed as NASDAQ: ICAD.

If you're new to stock investing, here's how to buy Icad stock.

What is the 52 week high and low for Icad (NASDAQ: ICAD)?

(NASDAQ: ICAD) Icad's 52-week high was $7.65, and its 52-week low was $1.61. It is currently -77.51% from its 52-week high and 6.83% from its 52-week low.

How much is Icad stock worth today?

(NASDAQ: ICAD) Icad currently has 25,446,407 outstanding shares. With Icad stock trading at $1.72 per share, the total value of Icad stock (market capitalization) is $43.77M.

Icad stock was originally listed at a price of $7.20 in Dec 31, 1997. If you had invested in Icad stock at $7.20, your return over the last 24 years would have been -76.11%, for an annualized return of -5.79% (not including any dividends or dividend reinvestments).

How much is Icad's stock price per share?

(NASDAQ: ICAD) Icad stock price per share is $1.72 today (as of Dec 1, 2022).

What is Icad's Market Cap?

(NASDAQ: ICAD) Icad's market cap is $43.77M, as of Dec 3, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Icad's market cap is calculated by multiplying ICAD's current stock price of $1.72 by ICAD's total outstanding shares of 25,446,407.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.